Pharmacogenomic (PGx) implementation is increasing in the US, especially in cardiology where there is wide variability in medication response and strong evidence of the impact of genetic variation on medication outcomes. Commonly prescribed cardiovascular medications like clopidogrel, statins, and warfarin have Clinical Pharmacogenetics Implementation Consortium (CPIC) and/or FDA have PGx-based prescribing guidance. However, clinicians report low knowledge and confidence in using PGx information for adjusting dose or drug selection. This barrier must be overcome by clinicians who are responsible for integrating PGx into their practice to achieve positive outcomes.
- Provider:University of Pittsburgh
- Activity Link: https://cce.upmc.com/
- Start Date: 2024-08-01 05:00:00
- End Date: 2024-08-01 05:00:00
- Credit Details: IPCE Credits: 5.0 hours
AAPA Category 1 Credit™️: 5.0 hours
AMA PRA Category 1 Credit™️: 5.0 hours
Nursing: 5.0 hours
Pharmacy: 5.0 hours - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all